Tian Zhang

13.0k total citations · 5 hit papers
334 papers, 6.8k citations indexed

About

Tian Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tian Zhang has authored 334 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pulmonary and Respiratory Medicine, 139 papers in Oncology and 75 papers in Surgery. Recurrent topics in Tian Zhang's work include Renal cell carcinoma treatment (74 papers), Cancer Immunotherapy and Biomarkers (68 papers) and Prostate Cancer Treatment and Research (49 papers). Tian Zhang is often cited by papers focused on Renal cell carcinoma treatment (74 papers), Cancer Immunotherapy and Biomarkers (68 papers) and Prostate Cancer Treatment and Research (49 papers). Tian Zhang collaborates with scholars based in United States, China and Canada. Tian Zhang's co-authors include Andrew Z. Wang, Andrew J. Armstrong, Joseph M. Caster, Zihai Li, Daniel J. George, Daniel J. George, Longzhen Zhang, Lei Zheng, Delong Liu and Wenru Song and has published in prestigious journals such as The Lancet, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Tian Zhang

301 papers receiving 6.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Michael J. Eblan, Joseph M. Caster et al. profile →
Combination strategies to maximize the benefits of cancer immunotherapy

2021 442 citations Tian Zhang et al. profile →
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma

2018 371 citations Tian Zhang et al. profile →
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline

2022 175 citations Matthew I. Milowsky, Tian Zhang et al. Journal of Clinical Oncology profile →
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

2021 170 citations Daniel J. George, Tian Zhang et al. profile →

Peers

Tian Zhang

PRM

ONCOL

Xian Shen China

Tao Wang China

Eun Kyung Choi South Korea

Nicola J. Brown United Kingdom

Yifan Wang China

Xuelei Ma China

John A. Petros United States

Giuseppe Toffoli Italy

Sam M. Janes United Kingdom

Ligong Lu China

Xian Shen China

Tian Zhang

1.3k ×0.5

PRM

2.4k ×1.0

1.5k ×0.7

ONCOL

1.4k ×1.0

832 ×0.6

Citations per year, relative to Tian Zhang Tian Zhang (= 1×) peers Xian Shen

Countries citing papers authored by Tian Zhang

Since Specialization

Citations

This map shows the geographic impact of Tian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Zhang more than expected).

Fields of papers citing papers by Tian Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Zhang. The network helps show where Tian Zhang may publish in the future.

Co-authorship network of co-authors of Tian Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Zhang. A scholar is included among the top collaborators of Tian Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Zhang. Tian Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Liang, Tian Zhang, Qingming Zhang, & Xiaozhou Mou. (2025). Smart self-assembled nanomedicine for ferroptotic tumor therapy. Colloids and Interface Science Communications. 66. 100829–100829.

Tachibana, Isamu, et al.. (2025). A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma. Cancers. 17(2). 312–312. 1 indexed citations

Li, Runtao, Tian Zhang, Lei An, et al.. (2025). Lymphocyte‐Mimicking Sonosensitizers Boost Cancer Immunotherapy via Sequential Ultrasound Activation. Advanced Functional Materials. 35(45).

Bhanvadia, Raj, Isamu Tachibana, Solomon L. Woldu, et al.. (2025). Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis. Clinical Genitourinary Cancer. 23(2). 102307–102307. 3 indexed citations

Chen, Dapeng, et al.. (2024). Molecular endoperoxides for optical imaging and photodynamic therapy. Coordination Chemistry Reviews. 523. 216258–216258. 22 indexed citations

Zhang, Tian, Solomon L. Woldu, Qian Qin, et al.. (2024). 2022TiP Stereotactic treatment with neoadjuvant radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV). Annals of Oncology. 35. S1165–S1165. 1 indexed citations

Zhang, Jian, et al.. (2024). Automatic metabolism modulator for glycolytic intervention‐induced cascade cancer therapy. 3(1). 4 indexed citations

Ren, Luping, et al.. (2024). Unveiling the hidden impact: Subclinical hypercortisolism and its subtle influence on bone health. Aging Medicine. 7(1). 96–102. 2 indexed citations

Funt, Samuel A., Petros Grivas, Xīn Gào, et al.. (2024). Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.. Journal of Clinical Oncology. 42(16_suppl). 4575–4575. 1 indexed citations

10.

Aliru, Maureen, Song Zhang, Jue Wang, et al.. (2024). Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates.. Journal of Clinical Oncology. 42(16_suppl). 5078–5078.

11.

Kaye, Deborah R., J. Kelly Davis, Sharron L. Docherty, et al.. (2024). Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study. JU Open Plus. 2(3).

12.

Qin, Qian, et al.. (2023). Toxicity Management of Systemic Kidney Cancer Therapies. Hematology/Oncology Clinics of North America. 37(5). 993–1003. 4 indexed citations

13.

Dong, Jie, Tian Zhang, Wencheng Zhang, et al.. (2023). Advantages of nasogastric tube feeding during neoadjuvant concurrent chemoradiotherapy for esophageal cancer: A retrospective study. SHILAP Revista de lepidopterología. 4(2). 98–103. 1 indexed citations

14.

Zhang, Huifang, Huiming Liu, Dan Wang, et al.. (2022). Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation. Acta Pharmacologica Sinica. 44(5). 1051–1065. 27 indexed citations

15.

Spees, Lisa P., Stephanie B. Wheeler, Bradford E. Jackson, et al.. (2021). Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Cancer Medicine. 10(19). 6653–6665. 3 indexed citations

16.

Brown, Landon C., Kunal Desai, Wei Wei, et al.. (2021). Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal for ImmunoTherapy of Cancer. 9(9). e003281–e003281. 13 indexed citations

17.

Zhang, Tian, et al.. (2019). MicroRNA-448 inhibits the regeneration of spinal cord injury through PI3K/AKT/Bcl-2 axis.. PubMed. 23(7). 2719–2726. 10 indexed citations

18.

Myung, Ja Hye, Michael J. Eblan, Joseph M. Caster, et al.. (2018). Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. Clinical Cancer Research. 24(11). 2539–2547. 34 indexed citations

19.

Cai, Wangyu, Gang Chen, Qicong Luo, et al.. (2017). PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells. Molecular Cancer Therapeutics. 16(6). 1187–1198. 37 indexed citations

20.

Zhang, Tian, Rengasamy Boominathan, Brad Foulk, et al.. (2016). Development of a Novel c-MET–Based CTC Detection Platform. Molecular Cancer Research. 14(6). 539–547. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact